AstraZeneca’s Q1 revenue and operating profit decline

Generic competition and government austerity measures contributed to a 4% decline in 2011 first-quarter revenue at AstraZeneca Plc while core operating profit fell by 5% . But earnings per share rose by 10% helped by a recent tax settlement.